Garcia-Samaniego, Javier

Publishing since 1992 (Senior)

Has published 104 publications in 18 years

Number of publications published per year by Garcia-Samaniego, Javier. (Source : PubMed)

Distribution of publications types for Garcia-Samaniego, Javier. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Romero-Gómez M, Diago M, Andrade RJ, Calleja JL, Salmerón J, Fernández-Rodríguez CM, Solà R, García-Samaniego J, Herrerías JM, De la Mata M, Moreno-Otero R, Nuñez O, Olveira A, Durán S, Planas R. Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin.  Hepatology  2009;50;6  
•  Madejón A, Vispo E, Bottecchia M, Sánchez-Carrillo M, García-Samaniego J, Soriano V. Lack of hepatitis E virus infection in HIV patients with advanced immunodeficiency or idiopathic liver enzyme elevations.  J. Viral Hepat.  2009;16;12  
•  Medrano J, Barreiro P, Resino S, Tuma P, Rodríguez V, Vispo E, Labarga P, Madejón A, García-Samaniego J, Jiménez-Nácher I, Martín-Carbonero L, Soriano V. Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients.  Clin. Infect. Dis.  2009;49;9  
•  Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.  J. Viral Hepat.  2009;16;11  
•  Núñez-Fernández C, Martín-Carbonero L, Valencia ME, Aguilera J, García-Samaniego J, Gonzalez-Lahoz J, Soriano V. Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid.  AIDS Res. Hum. Retroviruses  2009;25;4  
•  Moreno S, García-Samaniego J, Moreno A, Ortega E, Pineda JA, del Romero J, Tural C, von Wichmann MA, Berenguer J, Castro A, Espacio R. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.  J. Viral Hepat.  2009;16;4  
•  Tural C, Tor J, Sanvisens A, Pérez-Alvarez N, Martínez E, Ojanguren I, García-Samaniego J, Rockstroh J, Barluenga E, Muga R, Planas R, Sirera G, Rey-Joly C, Clotet B. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.  Clin. Gastroenterol. Hepatol.  2009;7;3  
•  Erhardt A, Deterding K, Benhamou Y, Reiser M, Forns X, Pol S, Calleja JL, Ross S, Spangenberg HC, Garcia-Samaniego J, Fuchs M, Enríquez J, Wiegand J, Stern J, Wu K, Kukolj G, Marquis M, Beaulieu P, Nehmiz G, Steffgen J. Safety, pharmacokinetics and antiviral effect of BILB 1941, a novel hepatitis C virus RNA polymerase inhibitor, after 5 days oral treatment.  Antivir. Ther. (Lond.)  2009;14;1  
•  Rallón NI, López M, Soriano V, García-Samaniego J, Romero M, Labarga P, García-Gasco P, González-Lahoz J, Benito JM. Level, phenotype and activation status of CD4+FoxP3+ regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus.  Clin. Exp. Immunol.  2009;155;1  
•  Martín-Carbonero L, Puoti M, García-Samaniego J, De Luca A, Losada E, Quinzan G, Bruno R, Mariño A, González M, Núñez M, Soriano V. Response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C due to genotype 4.  J. Viral Hepat.  2008;15;10  

[ See timeline ] [ See all publications ]